A
ADIL
Adial製藥
1.690
-0.040-2.31%After Hours: 1.749 +0.059 +3.48%19:59 04/02 EDT
OPEN/PREV CLOSE1.690/1.730
TODAY RANGE1.670-1.750
VOL48.58K
MARKET CAP2.41M
52 WEEK RANGE1.540-30.25
AVG VOL (3M)83.41K
% TURNOVER3.40%
TURNOVER--
P/E (TTM)-0.1417
% RANGE4.62%
EPS(TTM)-11.9306
P/E(FORWARD)-0.2302
P/B0.3558
BVPS4.749
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.84M
SHARES OUTSTANDING1.43M
NEXT EARNINGS05/12-05/18
FREE FLOAT1.09M
LOT SIZE1
EX-DATE02/06/2026
News
Press Releases
Financial Reports
Profile
Benzinga·03/24 13:13
Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder
Seeking Alpha·03/06 19:05
Adial Pharmaceuticals reports FY results
Benzinga·03/06 13:07
Adial Pharmaceuticals Q4 EPS $(11.48) Misses $(0.09) Estimate
TipRanks·03/06 13:06
Adial Pharmaceuticals expects cash to fund operations into 2H of 2026
Dow Jones·03/06 13:05
*Adial Pharmaceuticals 2025 Loss $8M >ADIL
Dow Jones·03/06 13:00
Press Release: Adial Pharmaceuticals Reports 2025 -2-
Reuters·03/05 22:04
Adial Pharma posts FY 2025 net loss of USD 8.0 million, down 40%
Benzinga·03/04 17:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
TipRanks·03/03 13:48
Adial Pharmaceuticals Secures European Partnership for AD04 Commercialization
TipRanks·03/03 13:35
Adial Pharmaceuticals enters collaboration framework agreement with Molteni
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.